Procter & Gamble Hygiene and Health Care Limited
PGHH · FMCG · NSE
₹8,994
Current Market Price
Fair Value (DCF)
₹9,160
Discount to FV
+1.8%
Updated just now
YieldIQ Score
58/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
84%
ROE
10.5%
Debt/Equity
—
WACC
10.4%
Market Cap
₹29,194 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
14.5%
Return on capital employed
EV / EBITDA
25.2×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
35.8×
EBIT covers interest
Current Ratio
1.22×
Short-term liquidity
Asset Turnover
2.30×
Revenue per ₹ of assets
Revenue CAGR (3Y)
4.1%
3-year revenue growth
Revenue CAGR (5Y)
7.4%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹8,993.5
Bear case
Discount -70.6%
Base case
Discount +1.8%
Bull case
Discount +18.2%
Ratio Trends
PGHH · last 6 annual periods
ROE
10.5%
ROCE
14.5%
Operating Margin
—
Debt / Equity
—
PE
303.6×
EV / EBITDA
49.4×
Historical Financials
PGHH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹3570 Cr | ₹3792 Cr | ₹3905 Cr | ₹4192 Cr | ₹4282 Cr | +4.6% |
| EBITDA | ₹924 Cr | ₹854 Cr | ₹909 Cr | ₹1023 Cr | ₹1214 Cr | +7.1% |
| EBIT | ₹876 Cr | ₹801 Cr | ₹851 Cr | ₹966 Cr | — | +2.5% |
| PAT | ₹652 Cr | ₹576 Cr | ₹678 Cr | ₹675 Cr | ₹857 Cr | +7.1% |
| EPS (diluted) | ₹200.79 | ₹177.37 | ₹208.91 | ₹207.95 | — | +0.9% |
| CFO | ₹863 Cr | ₹573 Cr | ₹826 Cr | ₹471 Cr | ₹924 Cr | +1.7% |
| CapEx | ₹-31.6 Cr | ₹-49.8 Cr | ₹-44.4 Cr | ₹-44.7 Cr | ₹-49.5 Cr | — |
| FCF | ₹832 Cr | ₹523 Cr | ₹781 Cr | ₹426 Cr | ₹875 Cr | +1.3% |
| Total Assets | ₹1633 Cr | ₹1683 Cr | ₹2137 Cr | ₹1859 Cr | ₹1804 Cr | +2.5% |
| Total Debt | ₹3.5 Cr | ₹5.1 Cr | ₹4.0 Cr | ₹3.1 Cr | ₹0.9 Cr | -29.2% |
| Shareholders' Equity | ₹714 Cr | ₹738 Cr | ₹946 Cr | ₹775 Cr | ₹753 Cr | +1.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PGHH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 GILLETTE Gillette India Limited | -22.8% | 61 | Near Fair Value | 42.4% | — |
 COLPAL COLPAL | — | — | Pending | 83.7% | 36.7× |
 DABUR DABUR | — | — | Pending | 16.6% | 38.4× |
 MARICO MARICO | — | — | Pending | 41.9% | 54.1× |
 GODREJCP GODREJCP | — | — | Pending | 14.7% | 54.1× |
Click a ticker to view its fair-value analysis.
Dividend History
19 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹1,050.00/sh
Last payout
2026-02-05
₹195.00
Peak payout
₹362.00
Trailing yield
2.89%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Procter & Gamble Hygiene and Health Care Limited (PGHH.NS) trades at 8993.50 vs a model fair value of 9159.83, a gap of 1.8%. Piotroski F...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PGHH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PGHH →
Compare
Head-to-head with peers
Compare PGHH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PGHHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.